Global Budesonide Capsules Market Growth 2025-2031

October 2025 | 89 pages | ID: G8E73F6885EEN
LP Information

Abstracts

The global Budesonide Capsules market size is predicted to grow from US$ 1118 million in 2025 to US$ 1921 million in 2031; it is expected to grow at a CAGR of 9.4% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Budesonide is a first-line anti-inflammatory agent and locally acting glucocorticosteroid indicated for the induction and maintenance of remission of mild to moderate ileocaecal Crohn's disease (capsules) and ulcerative colitis (enemas) as well as for the remission of active microscopic colitis (capsules).

United States market for Budesonide Capsules is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Budesonide Capsules is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Budesonide Capsules is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Budesonide Capsules players cover Perrigo, Mylan, Tillotts Pharma, Teva, Zydus Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the ?Budesonide Capsules Industry Forecast? looks at past sales and reviews total world Budesonide Capsules sales in 2024, providing a comprehensive analysis by region and market sector of projected Budesonide Capsules sales for 2025 through 2031. With Budesonide Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Budesonide Capsules industry.

This Insight Report provides a comprehensive analysis of the global Budesonide Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Budesonide Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Budesonide Capsules market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Budesonide Capsules and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Budesonide Capsules.

This report presents a comprehensive overview, market shares, and growth opportunities of Budesonide Capsules market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 1mg
• 2mg
• 3mg

Segmentation by Application:

• Crohn's Disease
• Collagenous Colitis
• Autoimmune Hepatitis

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Perrigo
• Mylan
• Tillotts Pharma
• Teva
• Zydus Pharmaceuticals
• Amneal
• Mayne Pharma
• Sciecure Pharma

Key Questions Addressed in this Report

What is the 10-year outlook for the global Budesonide Capsules market?
What factors are driving Budesonide Capsules market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Budesonide Capsules market opportunities vary by end market size?
How does Budesonide Capsules break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Budesonide Capsules Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Budesonide Capsules by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Budesonide Capsules by Country/Region, 2020, 2024 & 2031
2.2 Budesonide Capsules Segment by Type
  2.2.1 1mg
  2.2.2 2mg
  2.2.3 3mg
2.3 Budesonide Capsules Sales by Type
  2.3.1 Global Budesonide Capsules Sales Market Share by Type (2020-2025)
  2.3.2 Global Budesonide Capsules Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Budesonide Capsules Sale Price by Type (2020-2025)
2.4 Budesonide Capsules Segment by Application
  2.4.1 Crohn's Disease
  2.4.2 Collagenous Colitis
  2.4.3 Autoimmune Hepatitis
2.5 Budesonide Capsules Sales by Application
  2.5.1 Global Budesonide Capsules Sale Market Share by Application (2020-2025)
  2.5.2 Global Budesonide Capsules Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Budesonide Capsules Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Budesonide Capsules Breakdown Data by Company
  3.1.1 Global Budesonide Capsules Annual Sales by Company (2020-2025)
  3.1.2 Global Budesonide Capsules Sales Market Share by Company (2020-2025)
3.2 Global Budesonide Capsules Annual Revenue by Company (2020-2025)
  3.2.1 Global Budesonide Capsules Revenue by Company (2020-2025)
  3.2.2 Global Budesonide Capsules Revenue Market Share by Company (2020-2025)
3.3 Global Budesonide Capsules Sale Price by Company
3.4 Key Manufacturers Budesonide Capsules Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Budesonide Capsules Product Location Distribution
  3.4.2 Players Budesonide Capsules Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR BUDESONIDE CAPSULES BY GEOGRAPHIC REGION

4.1 World Historic Budesonide Capsules Market Size by Geographic Region (2020-2025)
  4.1.1 Global Budesonide Capsules Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Budesonide Capsules Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Budesonide Capsules Market Size by Country/Region (2020-2025)
  4.2.1 Global Budesonide Capsules Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Budesonide Capsules Annual Revenue by Country/Region (2020-2025)
4.3 Americas Budesonide Capsules Sales Growth
4.4 APAC Budesonide Capsules Sales Growth
4.5 Europe Budesonide Capsules Sales Growth
4.6 Middle East & Africa Budesonide Capsules Sales Growth

5 AMERICAS

5.1 Americas Budesonide Capsules Sales by Country
  5.1.1 Americas Budesonide Capsules Sales by Country (2020-2025)
  5.1.2 Americas Budesonide Capsules Revenue by Country (2020-2025)
5.2 Americas Budesonide Capsules Sales by Type (2020-2025)
5.3 Americas Budesonide Capsules Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Budesonide Capsules Sales by Region
  6.1.1 APAC Budesonide Capsules Sales by Region (2020-2025)
  6.1.2 APAC Budesonide Capsules Revenue by Region (2020-2025)
6.2 APAC Budesonide Capsules Sales by Type (2020-2025)
6.3 APAC Budesonide Capsules Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Budesonide Capsules by Country
  7.1.1 Europe Budesonide Capsules Sales by Country (2020-2025)
  7.1.2 Europe Budesonide Capsules Revenue by Country (2020-2025)
7.2 Europe Budesonide Capsules Sales by Type (2020-2025)
7.3 Europe Budesonide Capsules Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Budesonide Capsules by Country
  8.1.1 Middle East & Africa Budesonide Capsules Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Budesonide Capsules Revenue by Country (2020-2025)
8.2 Middle East & Africa Budesonide Capsules Sales by Type (2020-2025)
8.3 Middle East & Africa Budesonide Capsules Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Budesonide Capsules
10.3 Manufacturing Process Analysis of Budesonide Capsules
10.4 Industry Chain Structure of Budesonide Capsules

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Budesonide Capsules Distributors
11.3 Budesonide Capsules Customer

12 WORLD FORECAST REVIEW FOR BUDESONIDE CAPSULES BY GEOGRAPHIC REGION

12.1 Global Budesonide Capsules Market Size Forecast by Region
  12.1.1 Global Budesonide Capsules Forecast by Region (2026-2031)
  12.1.2 Global Budesonide Capsules Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Budesonide Capsules Forecast by Type (2026-2031)
12.7 Global Budesonide Capsules Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Perrigo
  13.1.1 Perrigo Company Information
  13.1.2 Perrigo Budesonide Capsules Product Portfolios and Specifications
  13.1.3 Perrigo Budesonide Capsules Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Perrigo Main Business Overview
  13.1.5 Perrigo Latest Developments
13.2 Mylan
  13.2.1 Mylan Company Information
  13.2.2 Mylan Budesonide Capsules Product Portfolios and Specifications
  13.2.3 Mylan Budesonide Capsules Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Mylan Main Business Overview
  13.2.5 Mylan Latest Developments
13.3 Tillotts Pharma
  13.3.1 Tillotts Pharma Company Information
  13.3.2 Tillotts Pharma Budesonide Capsules Product Portfolios and Specifications
  13.3.3 Tillotts Pharma Budesonide Capsules Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Tillotts Pharma Main Business Overview
  13.3.5 Tillotts Pharma Latest Developments
13.4 Teva
  13.4.1 Teva Company Information
  13.4.2 Teva Budesonide Capsules Product Portfolios and Specifications
  13.4.3 Teva Budesonide Capsules Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Teva Main Business Overview
  13.4.5 Teva Latest Developments
13.5 Zydus Pharmaceuticals
  13.5.1 Zydus Pharmaceuticals Company Information
  13.5.2 Zydus Pharmaceuticals Budesonide Capsules Product Portfolios and Specifications
  13.5.3 Zydus Pharmaceuticals Budesonide Capsules Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Zydus Pharmaceuticals Main Business Overview
  13.5.5 Zydus Pharmaceuticals Latest Developments
13.6 Amneal
  13.6.1 Amneal Company Information
  13.6.2 Amneal Budesonide Capsules Product Portfolios and Specifications
  13.6.3 Amneal Budesonide Capsules Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Amneal Main Business Overview
  13.6.5 Amneal Latest Developments
13.7 Mayne Pharma
  13.7.1 Mayne Pharma Company Information
  13.7.2 Mayne Pharma Budesonide Capsules Product Portfolios and Specifications
  13.7.3 Mayne Pharma Budesonide Capsules Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Mayne Pharma Main Business Overview
  13.7.5 Mayne Pharma Latest Developments
13.8 Sciecure Pharma
  13.8.1 Sciecure Pharma Company Information
  13.8.2 Sciecure Pharma Budesonide Capsules Product Portfolios and Specifications
  13.8.3 Sciecure Pharma Budesonide Capsules Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Sciecure Pharma Main Business Overview
  13.8.5 Sciecure Pharma Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Budesonide Capsules Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Budesonide Capsules Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 1mg
Table 4. Major Players of 2mg
Table 5. Major Players of 3mg
Table 6. Global Budesonide Capsules Sales by Type (2020-2025) & (K Units)
Table 7. Global Budesonide Capsules Sales Market Share by Type (2020-2025)
Table 8. Global Budesonide Capsules Revenue by Type (2020-2025) & ($ million)
Table 9. Global Budesonide Capsules Revenue Market Share by Type (2020-2025)
Table 10. Global Budesonide Capsules Sale Price by Type (2020-2025) & (USD/Unit)
Table 11. Global Budesonide Capsules Sale by Application (2020-2025) & (K Units)
Table 12. Global Budesonide Capsules Sale Market Share by Application (2020-2025)
Table 13. Global Budesonide Capsules Revenue by Application (2020-2025) & ($ million)
Table 14. Global Budesonide Capsules Revenue Market Share by Application (2020-2025)
Table 15. Global Budesonide Capsules Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Budesonide Capsules Sales by Company (2020-2025) & (K Units)
Table 17. Global Budesonide Capsules Sales Market Share by Company (2020-2025)
Table 18. Global Budesonide Capsules Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Budesonide Capsules Revenue Market Share by Company (2020-2025)
Table 20. Global Budesonide Capsules Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Budesonide Capsules Producing Area Distribution and Sales Area
Table 22. Players Budesonide Capsules Products Offered
Table 23. Budesonide Capsules Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Budesonide Capsules Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Budesonide Capsules Sales Market Share Geographic Region (2020-2025)
Table 28. Global Budesonide Capsules Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Budesonide Capsules Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Budesonide Capsules Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Budesonide Capsules Sales Market Share by Country/Region (2020-2025)
Table 32. Global Budesonide Capsules Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Budesonide Capsules Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Budesonide Capsules Sales by Country (2020-2025) & (K Units)
Table 35. Americas Budesonide Capsules Sales Market Share by Country (2020-2025)
Table 36. Americas Budesonide Capsules Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Budesonide Capsules Sales by Type (2020-2025) & (K Units)
Table 38. Americas Budesonide Capsules Sales by Application (2020-2025) & (K Units)
Table 39. APAC Budesonide Capsules Sales by Region (2020-2025) & (K Units)
Table 40. APAC Budesonide Capsules Sales Market Share by Region (2020-2025)
Table 41. APAC Budesonide Capsules Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Budesonide Capsules Sales by Type (2020-2025) & (K Units)
Table 43. APAC Budesonide Capsules Sales by Application (2020-2025) & (K Units)
Table 44. Europe Budesonide Capsules Sales by Country (2020-2025) & (K Units)
Table 45. Europe Budesonide Capsules Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Budesonide Capsules Sales by Type (2020-2025) & (K Units)
Table 47. Europe Budesonide Capsules Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Budesonide Capsules Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Budesonide Capsules Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Budesonide Capsules Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa Budesonide Capsules Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Budesonide Capsules
Table 53. Key Market Challenges & Risks of Budesonide Capsules
Table 54. Key Industry Trends of Budesonide Capsules
Table 55. Budesonide Capsules Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Budesonide Capsules Distributors List
Table 58. Budesonide Capsules Customer List
Table 59. Global Budesonide Capsules Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global Budesonide Capsules Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Budesonide Capsules Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas Budesonide Capsules Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Budesonide Capsules Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC Budesonide Capsules Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Budesonide Capsules Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe Budesonide Capsules Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Budesonide Capsules Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Budesonide Capsules Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Budesonide Capsules Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global Budesonide Capsules Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Budesonide Capsules Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global Budesonide Capsules Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Perrigo Basic Information, Budesonide Capsules Manufacturing Base, Sales Area and Its Competitors
Table 74. Perrigo Budesonide Capsules Product Portfolios and Specifications
Table 75. Perrigo Budesonide Capsules Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Perrigo Main Business
Table 77. Perrigo Latest Developments
Table 78. Mylan Basic Information, Budesonide Capsules Manufacturing Base, Sales Area and Its Competitors
Table 79. Mylan Budesonide Capsules Product Portfolios and Specifications
Table 80. Mylan Budesonide Capsules Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Mylan Main Business
Table 82. Mylan Latest Developments
Table 83. Tillotts Pharma Basic Information, Budesonide Capsules Manufacturing Base, Sales Area and Its Competitors
Table 84. Tillotts Pharma Budesonide Capsules Product Portfolios and Specifications
Table 85. Tillotts Pharma Budesonide Capsules Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Tillotts Pharma Main Business
Table 87. Tillotts Pharma Latest Developments
Table 88. Teva Basic Information, Budesonide Capsules Manufacturing Base, Sales Area and Its Competitors
Table 89. Teva Budesonide Capsules Product Portfolios and Specifications
Table 90. Teva Budesonide Capsules Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Teva Main Business
Table 92. Teva Latest Developments
Table 93. Zydus Pharmaceuticals Basic Information, Budesonide Capsules Manufacturing Base, Sales Area and Its Competitors
Table 94. Zydus Pharmaceuticals Budesonide Capsules Product Portfolios and Specifications
Table 95. Zydus Pharmaceuticals Budesonide Capsules Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Zydus Pharmaceuticals Main Business
Table 97. Zydus Pharmaceuticals Latest Developments
Table 98. Amneal Basic Information, Budesonide Capsules Manufacturing Base, Sales Area and Its Competitors
Table 99. Amneal Budesonide Capsules Product Portfolios and Specifications
Table 100. Amneal Budesonide Capsules Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Amneal Main Business
Table 102. Amneal Latest Developments
Table 103. Mayne Pharma Basic Information, Budesonide Capsules Manufacturing Base, Sales Area and Its Competitors
Table 104. Mayne Pharma Budesonide Capsules Product Portfolios and Specifications
Table 105. Mayne Pharma Budesonide Capsules Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Mayne Pharma Main Business
Table 107. Mayne Pharma Latest Developments
Table 108. Sciecure Pharma Basic Information, Budesonide Capsules Manufacturing Base, Sales Area and Its Competitors
Table 109. Sciecure Pharma Budesonide Capsules Product Portfolios and Specifications
Table 110. Sciecure Pharma Budesonide Capsules Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Sciecure Pharma Main Business
Table 112. Sciecure Pharma Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Budesonide Capsules
Figure 2. Budesonide Capsules Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Budesonide Capsules Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Budesonide Capsules Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Budesonide Capsules Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Budesonide Capsules Sales Market Share by Country/Region (2024)
Figure 10. Budesonide Capsules Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 1mg
Figure 12. Product Picture of 2mg
Figure 13. Product Picture of 3mg
Figure 14. Global Budesonide Capsules Sales Market Share by Type in 2025
Figure 15. Global Budesonide Capsules Revenue Market Share by Type (2020-2025)
Figure 16. Budesonide Capsules Consumed in Crohn's Disease
Figure 17. Global Budesonide Capsules Market: Crohn's Disease (2020-2025) & (K Units)
Figure 18. Budesonide Capsules Consumed in Collagenous Colitis
Figure 19. Global Budesonide Capsules Market: Collagenous Colitis (2020-2025) & (K Units)
Figure 20. Budesonide Capsules Consumed in Autoimmune Hepatitis
Figure 21. Global Budesonide Capsules Market: Autoimmune Hepatitis (2020-2025) & (K Units)
Figure 22. Global Budesonide Capsules Sale Market Share by Application (2024)
Figure 23. Global Budesonide Capsules Revenue Market Share by Application in 2025
Figure 24. Budesonide Capsules Sales by Company in 2025 (K Units)
Figure 25. Global Budesonide Capsules Sales Market Share by Company in 2025
Figure 26. Budesonide Capsules Revenue by Company in 2025 ($ millions)
Figure 27. Global Budesonide Capsules Revenue Market Share by Company in 2025
Figure 28. Global Budesonide Capsules Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Budesonide Capsules Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Budesonide Capsules Sales 2020-2025 (K Units)
Figure 31. Americas Budesonide Capsules Revenue 2020-2025 ($ millions)
Figure 32. APAC Budesonide Capsules Sales 2020-2025 (K Units)
Figure 33. APAC Budesonide Capsules Revenue 2020-2025 ($ millions)
Figure 34. Europe Budesonide Capsules Sales 2020-2025 (K Units)
Figure 35. Europe Budesonide Capsules Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Budesonide Capsules Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa Budesonide Capsules Revenue 2020-2025 ($ millions)
Figure 38. Americas Budesonide Capsules Sales Market Share by Country in 2025
Figure 39. Americas Budesonide Capsules Revenue Market Share by Country (2020-2025)
Figure 40. Americas Budesonide Capsules Sales Market Share by Type (2020-2025)
Figure 41. Americas Budesonide Capsules Sales Market Share by Application (2020-2025)
Figure 42. United States Budesonide Capsules Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Budesonide Capsules Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Budesonide Capsules Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Budesonide Capsules Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Budesonide Capsules Sales Market Share by Region in 2025
Figure 47. APAC Budesonide Capsules Revenue Market Share by Region (2020-2025)
Figure 48. APAC Budesonide Capsules Sales Market Share by Type (2020-2025)
Figure 49. APAC Budesonide Capsules Sales Market Share by Application (2020-2025)
Figure 50. China Budesonide Capsules Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Budesonide Capsules Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Budesonide Capsules Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Budesonide Capsules Revenue Growth 2020-2025 ($ millions)
Figure 54. India Budesonide Capsules Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Budesonide Capsules Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Budesonide Capsules Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Budesonide Capsules Sales Market Share by Country in 2025
Figure 58. Europe Budesonide Capsules Revenue Market Share by Country (2020-2025)
Figure 59. Europe Budesonide Capsules Sales Market Share by Type (2020-2025)
Figure 60. Europe Budesonide Capsules Sales Market Share by Application (2020-2025)
Figure 61. Germany Budesonide Capsules Revenue Growth 2020-2025 ($ millions)
Figure 62. France Budesonide Capsules Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Budesonide Capsules Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Budesonide Capsules Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Budesonide Capsules Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Budesonide Capsules Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Budesonide Capsules Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Budesonide Capsules Sales Market Share by Application (2020-2025)
Figure 69. Egypt Budesonide Capsules Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Budesonide Capsules Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Budesonide Capsules Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Budesonide Capsules Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Budesonide Capsules Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Budesonide Capsules in 2025
Figure 75. Manufacturing Process Analysis of Budesonide Capsules
Figure 76. Industry Chain Structure of Budesonide Capsules
Figure 77. Channels of Distribution
Figure 78. Global Budesonide Capsules Sales Market Forecast by Region (2026-2031)
Figure 79. Global Budesonide Capsules Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Budesonide Capsules Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Budesonide Capsules Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Budesonide Capsules Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Budesonide Capsules Revenue Market Share Forecast by Application (2026-2031)